Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 5805-5809, October 15, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeSombre, E. R.
Right arrow Articles by Schwartz, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeSombre, E. R.
Right arrow Articles by Schwartz, J. L.

Bromine-80m Radiotoxicity and the Potential for Estrogen Receptor-directed Therapy with Auger Electrons1

Eugene R. DeSombre2, Paul V. Harper, Alun Hughes, Ronnie C. Mease3, S. John Gatley, Onofre T. DeJesus4 and Jeffrey L. Schwartz

Ben May Institute [E. R. D., A. H.], Franklin McLean Institute [P. V. H., S. J. G., O. T. D.], and Department of Radiation Oncology [J. L. S.], University of Chicago, Chicago, Illinois 60637; and Argonne National Laboratory [R. C. M., O. T. D.], Argonne, Illinois 60439

While theoretically feasible, estrogen receptor (ER)-directed radiotherapy of hormone-dependent cancers has not been realized because no ER-seeking ligand with an appropriate radiotoxic potential has been identified. Since an appropriate nuclide is a key component we studied the 4.4-h half-life, Auger electron-emitting nuclide bromine-80m. When incorporated into DNA this nuclide was radiotoxic to cells in culture and caused substantial chromosomal damage, while similar concentrations of bromine-80m as bromide or bromoantipyrine were without effect. The mean lethal dose for bromine-80m was 45 atoms per nucleus which is consistent with use in receptor-positive cancers with limited numbers of ER.

1 These studies were supported by the NIH (CA27476 and HD15513), DOE (contract W-31-109-Eng-38), and by the Julius J. Reingold Fellowship Fund.

2 To whom requests for reprints should be addressed, at the Ben May Institute, University of Chicago, 5841 South Maryland Avenue, Chicago, IL 60637.

3 Current address: Medical Division, Brookhaven National Laboratories, Associated Universities, Inc., Upton, Long Island, NY 11973.

4 Current address: Department of Medical Physics, University of Wisconsin Medical Center, 1300 University Avenue, Madison, WI 53706.

Received 3/16/88. Revised 7/ 6/88. Accepted 7/15/88.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.